Skip to content
Careers
Investors
Search
Sanuwave Wound Care Technologies
Our Energy First Approach
Our Technology
The dermaPACE
®
System
The UltraMIST
®
System
Our Products
Energy Systems
dermaPACE
®
System
UltraMIST
®
System
orthoPACE
®
System
Knowledge Center
Blog
Resources
About Us
Our Team
Board of Directors
News
Events
Careers
Contact
Extracorporeal Shockwave Therapy (ESWT)
Clinical Summary
Treatment of Diabetic Foot Ulcers: A Comparative Study of Extracorporeal Shockwave Therapy Versus Hyperbaric Oxygen Therapy
May 14, 2021
Clinical Summary
dermaPACE Combined Clinical Trial Results
May 14, 2021
Publication
Extracorporeal Shock Wave Treatment in Ischemic Tissues: What is the Appropriate Number of Shock Wave Impulses?
April 1, 2021
Publication
Microvascular response to shock wave application in striated skin muscle
April 1, 2021
Publication
Extracorporeal shock wave treatment modulates skin fibroblast recruitment and leukocyte infiltration for enhancing extended skin-flap survival
April 1, 2021
Publication
EXTRACORPOREAL SHOCKWAVE THERAPY (ESWT) IMPROVES HEALING OF CHRONIC ULCERS AND PATIENTS’ QUALITY OF LIFE
April 1, 2021
Publication
Molecular changes in diabetic foot ulcers
April 1, 2021
Publication
Extracorporeal shock wave treatment protects skin flaps against ischemia–reperfusion injury
April 1, 2021
Video
Energy First: Extracorporeal Shockwave Therapy (ESWT) in the Treatment of Diabetic Foot Ulcers
October 13, 2020
Publication
Focused shockwave therapy in diabetic foot ulcers: secondary endpoints of two multicentre randomised controlled trials
June 1, 2019
Posts navigation
Older posts
For Advanced Wound Care, Use Energy First
Our Energy First Approach
Our Technology
The dermaPACE
®
System
The UltraMIST
®
System
Our Products
Energy Systems
dermaPACE
®
System
UltraMIST
®
System
orthoPACE
®
System
Knowledge Center
Blog
Resources
About Us
Our Team
Board of Directors
News
Events
Careers
Contact
Careers
Investors
Search
Search
Back